Literature DB >> 23892609

Thrombospondins: old players, new games.

Olga Stenina-Adognravi1.   

Abstract

PURPOSE OF REVIEW: Thrombospondins (TSPs) are secreted extracellular matrix (ECM) proteins from TSP family, which consists of five homologous members. They share a complex domain structure and have numerous binding partners in ECM and multiple cell surface receptors. Information that has emerged over the past decade identifies TSPs as important mediators of cellular homeostasis, assigning new important roles in cardiovascular pathology to these proteins. RECENT
FINDINGS: Recent studies of the functions of TSP in the cardiovascular system, diabetes and aging, which placed several TSPs in a position of critical regulators, demonstrated the involvement of these proteins in practically every aspect of cardiovascular pathophysiology related to atherosclerosis: inflammation, immunity, leukocyte recruitment and function, function of vascular cells, angiogenesis, and responses to hypoxia, ischemia and hyperglycemia. TSPs are also critically important in the development and ultimate outcome of the complications associated with atherosclerosis--myocardial infarction, and heart hypertrophy and failure. Their expression and significance increase with age and with the progression of diabetes, two major contributors to the development of atherosclerosis and its complications.
SUMMARY: This overview of recent literature examines the latest information on the newfound functions of TSPs that emphasize the importance of ECM in cardiovascular homeostasis and pathology. The functions of TSPs in myocardium, vasculature, vascular complications of diabetes, aging and immunity are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23892609      PMCID: PMC3935726          DOI: 10.1097/MOL.0b013e3283642912

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  97 in total

1.  Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

Authors:  Sukhbir Kaur; Gema Martin-Manso; Michael L Pendrak; Susan H Garfield; Jeff S Isenberg; David D Roberts
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells.

Authors:  Anna-Pia Papageorgiou; Melissa Swinnen; Davy Vanhoutte; Thierry VandenDriessche; Marinee Chuah; Diana Lindner; Wouter Verhesen; Bart de Vries; Jan D'hooge; Esther Lutgens; Dirk Westermann; Peter Carmeliet; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2012-02-02       Impact factor: 10.787

3.  Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.

Authors:  M Streit; L Riccardi; P Velasco; L F Brown; T Hawighorst; P Bornstein; M Detmar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  CD47 deficiency confers cell and tissue radioprotection by activation of autophagy.

Authors:  David R Soto-Pantoja; Thomas W Miller; Michael L Pendrak; William G DeGraff; Camille Sullivan; Lisa A Ridnour; Mones Abu-Asab; David A Wink; Maria Tsokos; David D Roberts
Journal:  Autophagy       Date:  2012-08-09       Impact factor: 16.016

Review 5.  The role of the thrombospondins in healing myocardial infarcts.

Authors:  Khaled Chatila; Guofeng Ren; Ying Xia; Peter Huebener; Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-01

6.  Relation between serum thrombospondin-2 and cardiovascular mortality in older men screened for abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Paula Clancy; Graeme J Hankey; Paul E Norman
Journal:  Am J Cardiol       Date:  2013-03-22       Impact factor: 2.778

7.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

8.  A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II.

Authors:  Souad Belmadani; Juan Bernal; Chih-Chang Wei; Manuel A Pallero; Louis Dell'italia; Joanne E Murphy-Ullrich; Kathleen H Berecek
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

9.  Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis.

Authors:  Gema Martin-Manso; Dhammika H M L P Navarathna; Susana Galli; David R Soto-Pantoja; Svetlana A Kuznetsova; Maria Tsokos; David D Roberts
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more
  17 in total

Review 1.  Integration of pro- and anti-angiogenic signals by endothelial cells.

Authors:  Shideh Kazerounian; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2017-12-20       Impact factor: 5.782

Review 2.  A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression.

Authors:  Hong-Li Li; Qian-Yu Li; Min-Jie Jin; Chao-Fan Lu; Zhao-Yang Mu; Wei-Yi Xu; Jian Song; Yan Zhang; Sai-Yang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-17       Impact factor: 4.553

Review 3.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

4.  Altered expression of thrombospondin-1/-2 in the cortex and synaptophysin in the hippocampus after middle cerebral artery occlusion and reperfusion.

Authors:  Yu Wang; Wei Chen; Bin Hou; Yan Gao; Zhihui Li; Xu Li; Chenggang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

Review 5.  SWI/SNF chromatin-remodeling complexes in cardiovascular development and disease.

Authors:  Ariana Bevilacqua; Monte S Willis; Scott J Bultman
Journal:  Cardiovasc Pathol       Date:  2013-10-04       Impact factor: 2.185

6.  Thrombospondin-1 Modulates Actin Filament Remodeling and Cell Motility in Mouse Mammary Tumor cells in Vitro.

Authors:  Dorothy Ndishabandi; Cameron Duquette; Ghita El-Moatassim Billah; Millys Reyes; Mark Duquette; Jack Lawler; Shideh Kazerounian
Journal:  Discoveries (Craiova)       Date:  2014 Oct-Dec

Review 7.  Role of ACTH in the Interactive/Paracrine Regulation of Adrenal Steroid Secretion in Physiological and Pathophysiological Conditions.

Authors:  Hervé Lefebvre; Michaël Thomas; Céline Duparc; Jérôme Bertherat; Estelle Louiset
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-20       Impact factor: 5.555

8.  Deficiency of Thrombospondin-4 in Mice Does Not Affect Skeletal Growth or Bone Mass Acquisition, but Causes a Transient Reduction of Articular Cartilage Thickness.

Authors:  Anke Jeschke; Martin Bonitz; Maciej Simon; Stephanie Peters; Wolfgang Baum; Georg Schett; Wolfgang Ruether; Andreas Niemeier; Thorsten Schinke; Michael Amling
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

9.  microRNA-206 modulates an Rtn4a/Cxcr4a/Thbs3a axis in newly forming somites to maintain and stabilize the somite boundary formation of zebrafish embryos.

Authors:  Cheng-Yung Lin; Jun-Yu He; Chih-Wei Zeng; Moo-Rumg Loo; Wen-Yen Chang; Po-Hsiang Zhang; Huai-Jen Tsai
Journal:  Open Biol       Date:  2017-07       Impact factor: 6.411

Review 10.  The α2δ Subunit and Absence Epilepsy: Beyond Calcium Channels?

Authors:  Roberta Celli; Ines Santolini; Michela Guiducci; Gilles van Luijtelaar; Pasquale Parisi; Pasquale Striano; Roberto Gradini; Giuseppe Battaglia; Richard T Ngomba; Ferdinando Nicoletti
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.